Cancer Cell Cycles
- 6 December 1996
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 274 (5293) , 1672-1677
- https://doi.org/10.1126/science.274.5293.1672
Abstract
Uncontrolled cell proliferation is the hallmark of cancer, and tumor cells have typically acquired damage to genes that directly regulate their cell cycles. Genetic alterations affecting p16 INK4a and cyclin D1, proteins that govern phosphorylation of the retinoblastoma protein (RB) and control exit from the G 1 phase of the cell cycle, are so frequent in human cancers that inactivation of this pathway may well be necessary for tumor development. Like the tumor suppressor protein p53, components of this “RB pathway,” although not essential for the cell cycle per se, may participate in checkpoint functions that regulate homeostatic tissue renewal throughout life.Keywords
This publication has 136 references indexed in Scilit:
- Reversal of apoptosis by the leukaemia-associated E2A–HLF chimaeric transcription factorNature, 1996
- Abrogation of p27 by cDNA Antisense Suppresses Quiescence (G0 State) in FibroblastsJournal of Biological Chemistry, 1996
- The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibitedTrends in Biochemical Sciences, 1995
- Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindredsNature Genetics, 1995
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- Cyclin A is required in S phase in normal epithelial cellsBiochemical and Biophysical Research Communications, 1992
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971